Back
ProShares Ultra VIX Short-Term Futures ETF Vs. BioMarin Pharmaceutical, Inc. Industry Stock Comparison
Sell
2
UVXY
ProShares Ultra VIX Short-Term Futures ETF
Last Price:
$38.63
Seasonality Move:
48.95%
Buy
54
BMRN
BioMarin Pharmaceutical, Inc.
Last Price:
$61.19
Seasonality Move:
5.52%
Sell
2
ProShares Ultra VIX Short-Term Futures ETF (UVXY)
is a Sell
Is ProShares Ultra VIX Short-Term Futures ETF a Buy, Sell or Hold?
-
The current ProShares Ultra VIX Short-Term Futures ETF [UVXY] share price is $38.66. The Score for UVXY is 2, which is 96% below its historic median score of 50, and infers higher risk than normal.
-
UVXY is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk could be especially high.
Buy
54
BioMarin Pharmaceutical, Inc. (BMRN)
is a Buy
Is BioMarin Pharmaceutical, Inc. a Buy, Sell or Hold?
-
The current BioMarin Pharmaceutical, Inc. [BMRN] share price is $61.15. The Score for BMRN is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
-
BMRN is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
UVXY Stock Price Chart
What is ProShares Ultra VIX Short-Term Futures ETF's stock price today?
-
The ProShares Ultra VIX Short-Term Futures ETF share price today is $38.66Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and UVXY is experiencing selling pressure, which indicates risk of future bearish movement.
BMRN Stock Price Chart
What is BioMarin Pharmaceutical, Inc.'s stock price today?
-
The BioMarin Pharmaceutical, Inc. share price today is $61.15Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BMRN is experiencing slight buying pressure.
UVXY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 7.63 | Buy |
| Relative Strength Index (14 RSI): | 30.91 | Sell |
| Chaikin Money Flow: | -5858566 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (41.59 - 56.01) | Sell |
| Bollinger Bands (100): | (47.12 - 65.32) | Sell |
BMRN Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.19 | Buy |
| Relative Strength Index (14 RSI): | 73.39 | Buy |
| Chaikin Money Flow: | 7836963 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (52.19 - 56.01) | Buy |
| Bollinger Bands (100): | (52.65 - 57.43) | Buy |
UVXY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 41.87 | Sell |
| 20-day SMA: | 46.06 | Sell |
| 50-day SMA: | 51.66 | Sell |
| 200-day SMA: | 87.96 | Sell |
| 8-day EMA: | 21.51 | Buy |
| 20-day EMA: | 10.59 | Buy |
| 50-day EMA: | 4.63 | Buy |
| 200-day EMA: | 1.21 | Buy |
BMRN Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 53.6 | Buy |
| 20-day SMA: | 54.21 | Buy |
| 50-day SMA: | 53.61 | Buy |
| 200-day SMA: | 57.94 | Buy |
| 8-day EMA: | 54.44 | Buy |
| 20-day EMA: | 53.99 | Buy |
| 50-day EMA: | 54.1 | Buy |
| 200-day EMA: | 58.28 | Buy |
ProShares Ultra VIX Short-Term Futures ETF Earnings Growth & UVXY Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
BioMarin Pharmaceutical, Inc. Earnings Growth & BMRN Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.97 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.28 per share, and an increase next year of $1.68 per share.
ProShares Ultra VIX Short-Term Futures ETF Technical Analysis
| Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
BioMarin Pharmaceutical, Inc. Technical Analysis
| Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||